The DOJ and HHS reestablish the False Claims Act Working Group to enhance enforcement against healthcare fraud and abuse in federal programs, emphasizing compliance and whistleblower roles.
Detailed analysis of recent Medicare Advantage enforcement activities focused on broker arrangements, Oak Street settlement, and DOJ False Claims Act litigation impacting healthcare compliance and beneficiary protection.
U.S. government files False Claims Act complaint against medical billing company for submitting false Medicare claims related to unnecessary genetic tests.
The DOJ sued SelectQuote and major insurers over Medicare Advantage plan kickbacks, leading to a 19% stock drop. This case highlights key compliance risks in broker compensation and Medicare Advantage enrollment.
Genexe, LLC and others pay $6 million to resolve allegations of Medicare fraud involving medically unnecessary genetic tests and kickbacks. Enforcement in healthcare compliance continues.
Federal court permits whistleblower FCA claims alleging improper Medicare Part C billing by UnitedHealthcare of Georgia, highlighting compliance scrutiny in Medicare Advantage billing.
Federal court permits whistleblower's False Claims Act allegations against UnitedHealthcare for improper Medicare Advantage billing to move forward, highlighting legal risks in healthcare billing compliance.
Vault Medical Services agreed to pay $8 million to resolve False Claims Act allegations for improper COVID-19 billing under the federal Uninsured Program, highlighting compliance risks in federally funded healthcare programs.
Genexe and Immerge settle $6M case resolving false Medicare claims for unnecessary genetic tests involving kickbacks. Settlement addresses healthcare fraud and whistleblower suits under the False Claims Act.
The DOJ has reported that settlements and judgments for the False Claims Act exceeded $2.9 billion in FY 2024, primarily driven by healthcare fraud.
